Tipping the balance
Almost four in ten serious adverse drug reactions now listed in the labels of 12 targeted cancer therapies were not mentioned in the studies that led to their approval. Half the serious reactions that were [more]
targeted cancer therapies
Still waiting for the world to catch up
When Ignace Vergote opted to specialise in gynaecological oncology, his country wasn’t ready, and he’s been waiting for the world to catch up with him ever since. Professor Ignace Vergote is a busy man. Arranging [more]